Type: | combo |
Component1: | Levodopa |
Class1: | Dopamine agonist |
Component2: | Benserazide |
Class2: | Decarboxylase inhibitors |
Tradename: | Prolopa, Madopar, others[1] |
Pregnancy Au: | B3 |
Routes Of Administration: | By mouth |
Atc Prefix: | N04 |
Atc Suffix: | BA02 |
Legal Au: | S4 |
Legal Au Comment: | [2] |
Legal Ca: | Rx-only |
Legal Ca Comment: | [3] |
Legal Uk: | POM |
Legal Uk Comment: | [4] |
Legal Status: | Rx-only |
Kegg: | D02135 |
Levodopa/benserazide, sold under the brand name Prolopa among others, is a fixed-dose combination medication used for the treatment of Parkinson's disease.
Levodopa/benserazide is indicated for the treatment of Parkinson's disease with the exception of drug-induced parkinsonism.